These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24976227)

  • 41. Perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapy.
    Feng FY; Qian Y; Stenmark MH; Halverson S; Blas K; Vance S; Sandler HM; Hamstra DA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e361-7. PubMed ID: 21820250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy.
    Pierorazio PM; Lin BM; Mullins JK; Hyndman ME; Schaeffer EM; Han M; Partin AW; Pavlovich CP
    Urol Oncol; 2013 Jul; 31(5):589-94. PubMed ID: 21664838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perineural invasion on prostate needle biopsy does not predict biochemical failure following brachytherapy for prostate cancer.
    Weight CJ; Ciezki JP; Reddy CA; Zhou M; Klein EA
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):347-50. PubMed ID: 16545922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perineural invasion is a prognostic factor for biochemical failure after radical prostatectomy.
    Jeon HG; Bae J; Yi JS; Hwang IS; Lee SE; Lee E
    Int J Urol; 2009 Aug; 16(8):682-6. PubMed ID: 19602004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spatial distribution of positive cores improves the selection of patients with low-risk prostate cancer as candidates for active surveillance.
    Abdollah F; Suardi N; Capitanio U; Gallina A; Sun M; Villa L; Scattoni V; Bianchi M; Tutolo M; Fossati N; Karakiewicz P; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2013 Aug; 112(4):E234-42. PubMed ID: 23746297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathologic findings in radical prostatectomy specimens from patients eligible for active surveillance with highly selective criteria: a multicenter study.
    Beauval JB; Ploussard G; Soulié M; Pfister C; Van Agt S; Vincendeau S; Larue S; Rigaud J; Gaschignard N; Rouprêt M; Drouin S; Peyromaure M; Long JA; Iborra F; Vallancien G; Rozet F; Salomon L;
    Urology; 2012 Sep; 80(3):656-60. PubMed ID: 22770616
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria?
    Ploussard G; Salomon L; Xylinas E; Allory Y; Vordos D; Hoznek A; Abbou CC; de la Taille A
    J Urol; 2010 Feb; 183(2):539-44. PubMed ID: 20006888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy.
    Yu HH; Song DY; Tsai YY; Thompson T; Frassica DA; DeWeese TL
    Urology; 2007 Jul; 70(1):111-6. PubMed ID: 17656219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perineural invasion in prostate biopsy specimens is associated with increased bone metastasis in prostate cancer.
    Ciftci S; Yilmaz H; Ciftci E; Simsek E; Ustuner M; Yavuz U; Muezzinoglu B; Dillioglugil O
    Prostate; 2015 Nov; 75(15):1783-9. PubMed ID: 26286637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The independent impact of extended pattern biopsy on prostate cancer stage migration.
    Master VA; Chi T; Simko JP; Weinberg V; Carroll PR
    J Urol; 2005 Nov; 174(5):1789-93; discussion 1793. PubMed ID: 16217288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.
    Iremashvili V; Manoharan M; Rosenberg DL; Soloway MS
    BJU Int; 2013 Apr; 111(4):574-9. PubMed ID: 22564446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radical Prostatectomy Findings in Men on Active Surveillance: Variable Findings Dependent on Reason for Surgery and Entry Criteria.
    Matoso A; Hassan O; Petrozzino F; Rao BV; Carter HB; Epstein JI
    J Urol; 2015 Sep; 194(3):685-9. PubMed ID: 25725419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors?
    Chan TY; Chan DY; Stutzman KL; Epstein JI
    J Urol; 2001 Dec; 166(6):2181-4. PubMed ID: 11696731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancer.
    Sved PD; Gomez P; Manoharan M; Kim SS; Soloway MS
    J Urol; 2004 Jul; 172(1):98-102. PubMed ID: 15201746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does repeat biopsy affect the prognosis of patients with prostate cancer treated with radical prostatectomy? Analysis by the number of cores taken at initial biopsy.
    Park M; You D; Yoon JH; Jeong IG; Song C; Hong JH; Ahn H; Kim CS
    BJU Int; 2012 May; 109(10):1474-9. PubMed ID: 21933324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease.
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2005 Mar; 12(3):270-4. PubMed ID: 15828954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncological outcomes in patients potentially eligible for active surveillance who underwent radical prostatectomy.
    Blázquez C; Hernández V; de la Peña E; Díaz FJ; Martin MD; de la Morena JM; Llorente C
    Actas Urol Esp; 2013; 37(10):603-7. PubMed ID: 23850164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gleason score 7 prostate cancer on needle biopsy: relation of primary pattern 3 or 4 to pathological stage and progression after radical prostatectomy.
    Amin A; Partin A; Epstein JI
    J Urol; 2011 Oct; 186(4):1286-90. PubMed ID: 21862072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.
    Karram S; Trock BJ; Netto GJ; Epstein JI
    Am J Surg Pathol; 2011 Sep; 35(9):1351-5. PubMed ID: 21836493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.